MDT Stock Recent News
MDT LATEST HEADLINES
Medtronic's (MDT) rapid cadence of new product approvals is a strong foundation for future growth. However, the company also navigates some macroeconomic challenges.
Shares in Arecor Therapeutics PLC (AIM:AREC) rose in the wake of news it is teaming with US med-tech giant Medtronic to develop a new, high-concentration, thermostable insulin designed specifically for use in the latter's next-generation implantable insulin pumps. Arecor believes there is the potential for 'significant advancements' in treatment for a group of diabetes patients who find limited benefits from conventional therapies.
DUBLIN , May 9, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2024 on Thursday, May 23, 2024. A news release will be issued at approximately 5:45 a.m.
Arecor Therapeutics PLC (AIM:AREC) said it is teaming with US med-tech giant Medtronic to develop a new, high-concentration, thermostable insulin designed specifically for use in the latter's next-generation implantable insulin pumps. Arecor believes there is the potential for 'significant advancements' in treatment for a group of diabetes patients who find limited benefits from conventional therapies.
The latest trading day saw Medtronic (MDT) settling at $81.76, representing a +0.09% change from its previous close.
Recently, Zacks.com users have been paying close attention to Medtronic (MDT). This makes it worthwhile to examine what the stock has in store.
Medtronic (MDT) closed at $80.86 in the latest trading session, marking a +1.4% move from the prior day.
Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
While artificial intelligence may be useful for a variety of purposes – including asking silly questions we're afraid to pose in real life – the ultimate end game for digital intelligence could be to advance the human condition, which brings us to medical AI stocks. When conducted in a controlled environment, AI can help accelerate productivity.
Medtronic (MDT) reachead $80.57 at the closing of the latest trading day, reflecting a +1.37% change compared to its last close.